OWENS & MINOR INC (OMI) Stock Fundamental Analysis

NYSE:OMI • US6907321029

2.8 USD
+0.06 (+2.19%)
At close: Dec 31, 2025
2.86 USD
+0.06 (+2.14%)
After Hours: 12/31/2025, 8:22:18 PM
Fundamental Rating

3

Overall OMI gets a fundamental rating of 3 out of 10. We evaluated OMI against 102 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of OMI while its profitability can be described as average. OMI is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • OMI had positive earnings in the past year.
  • OMI had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: OMI reported negative net income in multiple years.
  • Each year in the past 5 years OMI had a positive operating cash flow.
OMI Yearly Net Income VS EBIT VS OCF VS FCFOMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -33.21%, OMI is doing worse than 84.16% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 10.36%, OMI belongs to the top of the industry, outperforming 81.19% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for OMI is below the industry average of 9.00%.
  • The 3 year average ROIC (6.37%) for OMI is below the current ROIC(10.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROIC 10.36%
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
OMI Yearly ROA, ROE, ROICOMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80

1.3 Margins

  • OMI has a Operating Margin (3.07%) which is comparable to the rest of the industry.
  • OMI's Operating Margin has improved in the last couple of years.
  • OMI's Gross Margin of 26.13% is in line compared to the rest of the industry. OMI outperforms 53.47% of its industry peers.
  • OMI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.07%
PM (TTM) N/A
GM 26.13%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
OMI Yearly Profit, Operating, Gross MarginsOMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so OMI is still creating some value.
  • OMI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, OMI has more shares outstanding
  • OMI has a better debt/assets ratio than last year.
OMI Yearly Shares OutstandingOMI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OMI Yearly Total Debt VS Total AssetsOMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

  • OMI has an Altman-Z score of 1.41. This is a bad value and indicates that OMI is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.41, OMI is doing worse than 66.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.41
ROIC/WACC1.56
WACC6.65%
OMI Yearly LT Debt VS Equity VS FCFOMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 0.86 indicates that OMI may have some problems paying its short term obligations.
  • OMI has a worse Current ratio (0.86) than 78.22% of its industry peers.
  • A Quick Ratio of 0.84 indicates that OMI may have some problems paying its short term obligations.
  • OMI has a worse Quick ratio (0.84) than 74.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.86
Quick Ratio 0.84
OMI Yearly Current Assets VS Current LiabilitesOMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2

3. Growth

3.1 Past

  • OMI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.29%.
  • Measured over the past years, OMI shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.10% on average per year.
  • OMI shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.09%.
  • OMI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.04% yearly.
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%

3.2 Future

  • Based on estimates for the next years, OMI will show a decrease in Earnings Per Share. The EPS will decrease by -0.88% on average per year.
  • Based on estimates for the next years, OMI will show a very negative growth in Revenue. The Revenue will decrease by -26.97% on average per year.
EPS Next Y-31.24%
EPS Next 2Y-19.68%
EPS Next 3Y-8.45%
EPS Next 5Y-0.88%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.4%
Revenue Next 5Y-26.97%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
OMI Yearly Revenue VS EstimatesOMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
OMI Yearly EPS VS EstimatesOMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 2.17, the valuation of OMI can be described as very cheap.
  • Based on the Price/Earnings ratio, OMI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • OMI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.99.
  • The Price/Forward Earnings ratio is 2.86, which indicates a rather cheap valuation of OMI.
  • Based on the Price/Forward Earnings ratio, OMI is valued cheaper than 100.00% of the companies in the same industry.
  • OMI is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.06, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 2.17
Fwd PE 2.86
OMI Price Earnings VS Forward Price EarningsOMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of OMI indicates a rather cheap valuation: OMI is cheaper than 94.06% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.04
OMI Per share dataOMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

  • OMI's earnings are expected to decrease with -8.45% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.1
EPS Next 2Y-19.68%
EPS Next 3Y-8.45%

0

5. Dividend

5.1 Amount

  • OMI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

OWENS & MINOR INC

NYSE:OMI (12/31/2025, 8:22:18 PM)

After market: 2.86 +0.06 (+2.14%)

2.8

+0.06 (+2.19%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners97.53%
Inst Owner Change-7.28%
Ins Owners3.39%
Ins Owner Change-0.91%
Market Cap216.58M
Revenue(TTM)6.71B
Net Income(TTM)-1.34B
Analysts50
Price Target5.75 (105.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.21%
Min EPS beat(2)-6.28%
Max EPS beat(2)6.69%
EPS beat(4)3
Avg EPS beat(4)5.48%
Min EPS beat(4)-6.28%
Max EPS beat(4)16.66%
EPS beat(8)7
Avg EPS beat(8)4.92%
EPS beat(12)10
Avg EPS beat(12)14.96%
EPS beat(16)13
Avg EPS beat(16)13.17%
Revenue beat(2)0
Avg Revenue beat(2)-57.22%
Min Revenue beat(2)-75.28%
Max Revenue beat(2)-39.15%
Revenue beat(4)0
Avg Revenue beat(4)-29.29%
Min Revenue beat(4)-75.28%
Max Revenue beat(4)-0.59%
Revenue beat(8)1
Avg Revenue beat(8)-14.88%
Revenue beat(12)4
Avg Revenue beat(12)-9.25%
Revenue beat(16)7
Avg Revenue beat(16)-6.69%
PT rev (1m)0%
PT rev (3m)-8.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.27%
EPS NY rev (1m)0%
EPS NY rev (3m)1.25%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-37.5%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 2.17
Fwd PE 2.86
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 5.04
EPS(TTM)1.29
EY46.07%
EPS(NY)0.98
Fwd EY35.02%
FCF(TTM)-4.69
FCFYN/A
OCF(TTM)-1.28
OCFYN/A
SpS86.71
BVpS-5.55
TBVpS-23.57
PEG (NY)N/A
PEG (5Y)0.1
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -33.21%
ROE N/A
ROCE 13.12%
ROIC 10.36%
ROICexc 10.59%
ROICexgc 113.35%
OM 3.07%
PM (TTM) N/A
GM 26.13%
FCFM N/A
ROA(3y)-2.73%
ROA(5y)-0.2%
ROE(3y)-22.09%
ROE(5y)-7.69%
ROIC(3y)6.37%
ROIC(5y)8.64%
ROICexc(3y)6.65%
ROICexc(5y)8.97%
ROICexgc(3y)17.92%
ROICexgc(5y)17.9%
ROCE(3y)8.06%
ROCE(5y)10.94%
ROICexgc growth 3Y-4.88%
ROICexgc growth 5Y26.45%
ROICexc growth 3Y-21.55%
ROICexc growth 5Y13.72%
OM growth 3Y-17.34%
OM growth 5Y15.68%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.28%
GM growth 5Y11.1%
F-Score2
Asset Turnover1.66
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 4.03
Cap/Depr 105.46%
Cap/Sales 3.93%
Interest Coverage 1.54
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.86
Quick Ratio 0.84
Altman-Z 1.41
F-Score2
WACC6.65%
ROIC/WACC1.56
Cap/Depr(3y)77.12%
Cap/Depr(5y)69.93%
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.29%
EPS 3Y-28.62%
EPS 5Y22.1%
EPS Q2Q%-40.48%
EPS Next Y-31.24%
EPS Next 2Y-19.68%
EPS Next 3Y-8.45%
EPS Next 5Y-0.88%
Revenue 1Y (TTM)-37.09%
Revenue growth 3Y3.03%
Revenue growth 5Y3.04%
Sales Q2Q%-74.37%
Revenue Next Year-74.09%
Revenue Next 2Y-50.65%
Revenue Next 3Y-36.4%
Revenue Next 5Y-26.97%
EBIT growth 1Y-30.13%
EBIT growth 3Y-14.84%
EBIT growth 5Y19.2%
EBIT Next Year23.37%
EBIT Next 3Y7.47%
EBIT Next 5YN/A
FCF growth 1Y-170.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-113.82%
OCF growth 3Y9.15%
OCF growth 5Y-0.56%

OWENS & MINOR INC / OMI FAQ

Can you provide the ChartMill fundamental rating for OWENS & MINOR INC?

ChartMill assigns a fundamental rating of 3 / 10 to OMI.


What is the valuation status of OWENS & MINOR INC (OMI) stock?

ChartMill assigns a valuation rating of 6 / 10 to OWENS & MINOR INC (OMI). This can be considered as Fairly Valued.


Can you provide the profitability details for OWENS & MINOR INC?

OWENS & MINOR INC (OMI) has a profitability rating of 4 / 10.


What is the financial health of OWENS & MINOR INC (OMI) stock?

The financial health rating of OWENS & MINOR INC (OMI) is 1 / 10.


What is the earnings growth outlook for OWENS & MINOR INC?

The Earnings per Share (EPS) of OWENS & MINOR INC (OMI) is expected to decline by -31.24% in the next year.